Market Place
Sourcing Support
Cytovation raises 6M for CY-101 Phase 2 in Adrenocortical Carcinoma
23 Apr 2025 //
GLOBENEWSWIRE
Cytovation Appoints Martin Dewhurst to its Board of Directors
13 Feb 2025 //
GLOBENEWSWIRE
Cancer Research UK, Cytovation Collaborate On Rare Cancer Treatment
23 Jan 2025 //
GLOBENEWSWIRE
Cytovation To Present CY-101 Trial Data At ESMO 2024
13 Sep 2024 //
GLOBENEWSWIRE
Cytovation Announces Appointment of Ellen Lubman to Board of Directors
20 Dec 2023 //
GLOBENEWSWIRE
Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study
11 Oct 2023 //
GLOBENEWSWIRE
Cytovation appoints Olav Hellebø to its Board of Directors
05 Jul 2023 //
GLOBENEWSWIRE
Cytovation raises $8 million in Series A extension financing round
02 Jun 2023 //
GLOBENEWSWIRE
Cytovation appoints Iman Barilero as Chief Development Officer
21 Mar 2023 //
GLOBENEWSWIRE
Cytovation announces first patient dosed in Ph2a investigating CyPep-1
15 Feb 2023 //
GLOBENEWSWIRE
Cytovation Strengthens its Board of Directors for Next Phase of Development
15 Sep 2022 //
PRNEWSWIRE
FDA accepts Cytovation`s IND application for PII combination studies of CyPep-1
18 May 2022 //
PRNEWSWIRE
Cytovation collaborates with Recurrent Respiratory Papillomatosis Foundation
08 Feb 2022 //
PRNEWSWIRE
Cytovation raises $20M in Series A financing round to develop CyPep-1
24 Jan 2022 //
PRNEWSWIRE
First Patient Dosed with CyPep-1 in Combination with KEYTRUDA®
15 Nov 2021 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.